Cargando…
Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
Severe influenza complications are often caused by Streptococcus pneumoniae infection, which presents the most common cause of community-acquired pneumonia. We evaluated in a mouse model an associated virus-bacterial vaccine based on seasonal live influenza vaccines (LAIV) and S. pneumoniae chimeric...
Autores principales: | Desheva, Yulia, Leontieva, Galina, Kramskaya, Tatiana, Losev, Igor, Petkova, Nadezhda, Rekstin, Andrey, Suvorov, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920162/ https://www.ncbi.nlm.nih.gov/pubmed/35266442 http://dx.doi.org/10.1080/21505594.2022.2049496 |
Ejemplares similares
-
Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022) -
Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019) -
Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019) -
Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021) -
Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)